Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery

Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery

Objective: Medullary thyroid carcinoma (MTC) is a rare malignancy secreting calcitonin (Ctn). We aimed to analyze the relationship between Ctn levels at different time points in patients with MTC, and evaluate its predictive effect on recurrence. Methods: A retrospective study of patients diagnosed...

Descripció completa

Dades bibliogràfiques
Autors principals:	Fengli Guo, Lijuan Li, Pengfei Gu, Guoqiang Zhang, Xianhui Ruan, Jingzhu Zhao, Xiangqian Zheng, Songfeng Wei, Ming Gao
Format:	Article
Idioma:	English
Publicat:	Elsevier 2024-04-01
Col·lecció:	Heliyon
Matèries:	Medullary thyroid carcinoma Calcitonin Normalization of calcitonin Biochemical cure Disease-free survival
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2405844024058882

Ítems similars

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
per: Wenliang Yue, et al.
Publicat: (2022-11-01)

Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
per: Fengli Guo, et al.
Publicat: (2024-05-01)

Calcitonin receptor expression in medullary thyroid carcinoma
per: Virginia Cappagli, et al.
Publicat: (2017-09-01)

Serum Biochemical Markers for Medullary Thyroid Carcinoma: An Update
per: Liu S, et al.
Publicat: (2024-04-01)

Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence
per: Qiaodan Zhu, et al.
Publicat: (2021-04-01)

Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
per: LI Rui, LIU Zhuoran, YAN Jiqi
Publicat: (2022-06-01)

To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
per: Rosaria Ruggeri, et al.
Publicat: (2018-12-01)

Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
per: Pierpaolo Trimboli, et al.
Publicat: (2018-06-01)

False positive results using calcitonin as a screening method for medullary thyroid carcinoma
per: Rafael Loch Batista, et al.
Publicat: (2013-01-01)

Diagnosis and treatment of medullary thyroid carcinoma-an update
per: CHEN Chengkun, GUO Bomin, DENG Xianzhao, WU Bo, FAN Youben
Publicat: (2022-06-01)

Metastatic medullary thyroid carcinoma: A case report
per: Mitra Niafar, et al.
Publicat: (2011-01-01)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
per: Sun Jung Kim, et al.
Publicat: (2021-11-01)

Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy
per: Yixuan Song, et al.
Publicat: (2024-09-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
per: Yoko Omi, et al.
Publicat: (2021-08-01)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
per: Stéphane Bardet, et al.
Publicat: (2023-01-01)

The role of procalcitonin in the follow-up of medullary thyroid cancer
per: Jacopo Manso, et al.
Publicat: (2023-01-01)

Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
per: Claudio Gambardella, et al.
Publicat: (2019-05-01)

Small cell medullary thyroid carcinoma: A diagnostic dilemma
per: Anuj Verma, et al.
Publicat: (2017-01-01)

Critically evaluated key points on hereditary medullary thyroid carcinoma
per: Daqi Zhang, et al.
Publicat: (2024-06-01)

Analysis of some prognostic factors significance for medullary thyroid cancer metastasis
per: V.O. Palamarchuk, et al.
Publicat: (2022-03-01)

Diagnostic Performance of Preoperative Calcitonin and Procalcitonin Tests for Differential Diagnosis of Medullary Thyroid Cancer
per: Il Youb Jeong, et al.
Publicat: (2024-08-01)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
per: Hyunju Park, et al.
Publicat: (2021-10-01)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
per: Daqi Zhang, et al.
Publicat: (2022-07-01)

Clinicopathological characteristics and prognostic analysis of medullary thyroid carcinoma in children and adolescents
per: LIU Wei , WANG Xiaojiang , ZHANG Jing , ZHU Weifeng , PENG Fengying , WANG Jianchao , XIAO Weijin , HU Dan
Publicat: (2021-11-01)

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study
per: Zan Jiao, et al.
Publicat: (2022-12-01)

Cytodiagnosis of medullary carcinoma thyroid- role of FNAC and serum calcitonin- A case report
per: Majed B Momin, et al.
Publicat: (2018-01-01)

SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
per: L. A. Ivanova, et al.
Publicat: (2015-04-01)

Calcitonin‐secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine‐needle aspirate calcitonin washout: A case report and review of the literature
per: Darryl Mason, et al.
Publicat: (2022-01-01)

Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis
per: Clotilde Sparano, et al.
Publicat: (2023-02-01)

A rare case of medullary carcinoma
per: O.Z. Lishchuk, et al.
Publicat: (2023-10-01)

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
per: E. V. Ryabchenko
Publicat: (2022-06-01)

Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study
per: Daqi Zhang, et al.
Publicat: (2024-01-01)

Diagnosis and treatment of medullary thyroid carcinoma: A case report
per: Xin Nie, et al.
Publicat: (2023-11-01)

Medullary carcinoma of thyroid: Case report and a review of literature
per: Ratna Priya, et al.
Publicat: (2016-01-01)

Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer
per: Samantha M. Siskind, MD, et al.
Publicat: (2024-11-01)

Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma
per: Pierpaolo Trimboli, et al.
Publicat: (2024-01-01)

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”
per: N. V. Severskaya, et al.
Publicat: (2022-08-01)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
per: Sena Turkdogan, et al.
Publicat: (2018-09-01)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
per: Muhammed Erkam Sencar, et al.
Publicat: (2022-02-01)

Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature
per: Adnan Zaina, et al.
Publicat: (2013-01-01)